Epigenetics of Myotonic Dystrophies: A Minireview
Open Access
- 22 November 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (22) , 12594
Abstract
Myotonic dystrophy type 1 and 2 (DM1 and DM2) are two multisystemic autosomal dominant disorders with clinical and genetic similarities. The prevailing paradigm for DMs is that they are mediated by an in trans toxic RNA mechanism, triggered by untranslated CTG and CCTG repeat expansions in the DMPK and CNBP genes for DM1 and DM2, respectively. Nevertheless, increasing evidences suggest that epigenetics can also play a role in the pathogenesis of both diseases. In this review, we discuss the available information on epigenetic mechanisms that could contribute to the DMs outcome and progression. Changes in DNA cytosine methylation, chromatin remodeling and expression of regulatory noncoding RNAs are described, with the intent of depicting an epigenetic signature of DMs. Epigenetic biomarkers have a strong potential for clinical application since they could be used as targets for therapeutic interventions avoiding changes in DNA sequences. Moreover, understanding their clinical significance may serve as a diagnostic indicator in genetic counselling in order to improve genotype–phenotype correlations in DM patients.Keywords
This publication has 84 references indexed in Scilit:
- Circulating miRNAs: cell–cell communication function?Frontiers in Genetics, 2013
- Deregulated MicroRNAs in Myotonic Dystrophy Type 2PLOS ONE, 2012
- Epigenetics in Nucleotide Repeat Expansion DisordersSeminars in Neurology, 2011
- Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in FinlandEuropean Journal of Human Genetics, 2011
- Regulation of chromatin by histone modificationsCell Research, 2011
- Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissuesHuman Molecular Genetics, 2010
- Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patientsJournal of Translational Medicine, 2010
- Instability and chromatin structure of expanded trinucleotide repeatsTrends in Genetics, 2009
- Premutation allele pool in myotonic dystrophy type 2Neurology, 2009
- miRNAS in normal and diseased skeletal muscleJournal of Cellular and Molecular Medicine, 2009